Giorgia obtained her PhD from Imperial College London (UK) and is now working as a postdoctoral research fellow at the University of British Columbia (UBC) in Vancouver, Canada.

During her PhD, Giorgia explored the biological underpinnings of major depressive disorder, and applied bioinformatic tools to neuroimaging, metabolomic and inflammatory data to identify biomarkers predictive of responses to antidepressant pharmacotherapy in a large clinical trial. Her expertise covers the areas of neuroscience, microbiota-gut-brain axis, metabolomics and biomarker discovery.

In her current position in the Jefferies lab at UBC, she is investigating the anti-inflammatory and antidepressant properties of psychedelic analogues in both animal models and in a clinical cohort. Her research interests lie in elucidating the role of the gut microbiota in mediating the antidepressant effects of psychedelic drugs.